BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 37862613)

  • 1. Family History and Risk of Renal Cell Carcinoma: A National Multiregister Case-Control Study.
    Jakobsson RG; Nasic S; Bratt O; Johansson ME; Grenabo Bergdahl A
    J Urol; 2024 Jan; 211(1):71-79. PubMed ID: 37862613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial renal cell carcinoma from the Swedish Family-Cancer Database.
    Liu H; Sundquist J; Hemminki K
    Eur Urol; 2011 Nov; 60(5):987-93. PubMed ID: 21621909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family history and risk of renal cell carcinoma: results from a case-control study and systematic meta-analysis.
    Clague J; Lin J; Cassidy A; Matin S; Tannir NM; Tamboli P; Wood CG; Wu X
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):801-7. PubMed ID: 19240244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-specific familial risks for renal cell carcinoma with evidence on recessive heritable effects.
    Hemminki K; Li X
    Kidney Int; 2004 Jun; 65(6):2298-302. PubMed ID: 15149343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family history and risk of renal cell carcinoma.
    Gago-Dominguez M; Yuan JM; Castelao JE; Ross RK; Yu MC
    Cancer Epidemiol Biomarkers Prev; 2001 Sep; 10(9):1001-4. PubMed ID: 11535554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of subsequent cancers in renal cell carcinoma survivors with a family history.
    Chen T; Fallah M; Sundquist K; Liu H; Hemminki K
    Eur J Cancer; 2014 Aug; 50(12):2108-18. PubMed ID: 24923229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Family history of cancer and renal cell cancer risk in Caucasians and African Americans.
    Karami S; Schwartz K; Purdue MP; Davis FG; Ruterbusch JJ; Munuo SS; Wacholder S; Graubard BI; Colt JS; Chow WH
    Br J Cancer; 2010 May; 102(11):1676-80. PubMed ID: 20442711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic DNA Hypomethylation and Risk of Renal Cell Carcinoma: A Case-Control Study.
    Mendoza-Pérez J; Gu J; Herrera LA; Tannir NM; Matin SF; Karam JA; Huang M; Chang DW; Wood CG; Wu X
    Clin Cancer Res; 2016 Apr; 22(8):2074-82. PubMed ID: 26655847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Renal Cell Carcinoma and Myelodysplastic Syndromes: Epigenetic Underpinning?
    Shenoy N; Mudireddy M; Vallapureddy R; Leung N; Pagliaro L; Witzig T; Ou FS; Ordog T; Cheville J; Patnaik M; Thompson RH; Tefferi A; Begna K
    Clin Genitourin Cancer; 2018 Dec; 16(6):e1117-e1122. PubMed ID: 30077464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A population-based familial aggregation analysis indicates genetic contribution in a majority of renal cell carcinomas.
    Gudbjartsson T; Jónasdóttir TJ; Thoroddsen A; Einarsson GV; Jónsdóttir GM; Kristjánsson K; Hardarson S; Magnússon K; Gulcher J; Stefánsson K; Amundadóttir LT
    Int J Cancer; 2002 Aug; 100(4):476-9. PubMed ID: 12115533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal cell cancer histological subtype distribution differs by race and sex.
    Lipworth L; Morgans AK; Edwards TL; Barocas DA; Chang SS; Herrell SD; Penson DF; Resnick MJ; Smith JA; Clark PE
    BJU Int; 2016 Feb; 117(2):260-5. PubMed ID: 25307281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Familial Risk of Renal Cell Cancer and Interaction with Obesity and Hyperglycemia: A Population-Based Study.
    Lee SW; Kim HJ; Kazmi SZ; Choi YJ; Hong G; Kim YS; Eom J; Swan H; Cha J; Kang T; Hann HJ; Ahn HS
    J Urol; 2022 Aug; 208(2):251-258. PubMed ID: 35298291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence of renal cell carcinoma and hematologic malignancies (predominantly lymphoid) in individuals and in families.
    Dutcher JP; Wiernik PH; Varella L; Chintapatla R
    Fam Cancer; 2016 Oct; 15(4):677-87. PubMed ID: 27334456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.
    Syed JS; Nguyen KA; Holford TR; Hofmann JN; Shuch B
    Cancer; 2019 Jan; 125(2):232-238. PubMed ID: 30561791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma (RCC) arising in native kidneys of dialyzed and transplant patients: are they different entities?
    Gigante M; Neuzillet Y; Patard JJ; Tillou X; Thuret R; Branchereau J; Timsit MO; Terrier N; Boutin JM; Sallusto F; Karam G; Barrou B; Chevallier D; Mazzola CR; Delaporte V; Doeffler A; Kleinclauss F; Badet L; ;
    BJU Int; 2012 Dec; 110(11 Pt B):E570-3. PubMed ID: 22726451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renal cell cancer database Sweden (RCCBaSe) - a new register-based resource for renal cell carcinoma research.
    Landberg A; Lindblad P; Harmenberg U; Lundstam S; Ljungberg B; Thorstenson A; Sundqvist P
    Scand J Urol; 2020 Jun; 54(3):235-240. PubMed ID: 32436435
    [No Abstract]   [Full Text] [Related]  

  • 17. Early life body size in relation to risk of renal cell carcinoma in adulthood: a Danish observational cohort study.
    Jensen BW; Meyle KD; Madsen K; Sørensen TIA; Baker JL
    Eur J Epidemiol; 2020 Mar; 35(3):251-258. PubMed ID: 31993884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Variants Identified in Patients with Early-onset Renal Cell Carcinoma Referred for Germline Genetic Testing.
    Truong H; Sheikh R; Kotecha R; Kemel Y; Reisz PA; Lenis AT; Mehta NN; Khurram A; Joseph V; Mandelker D; Latham A; Ceyhan-Birsoy O; Ladanyi M; Shah NJ; Walsh MF; Voss MH; Lee CH; Russo P; Coleman JA; Hakimi AA; Feldman DR; Stadler ZK; Robson ME; Motzer RJ; Offit K; Patil S; Carlo MI
    Eur Urol Oncol; 2021 Dec; 4(6):993-1000. PubMed ID: 34654685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased risk for renal cell carcinoma in end stage renal disease - a population-based case-control study.
    Åkerlund J; Holmberg E; Lindblad P; Stendahl M; Ljungberg B; Thorstenson A; Lundstam S
    Scand J Urol; 2021 Jun; 55(3):209-214. PubMed ID: 33769206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High circulating insulin-like growth factor-1 reduces the risk of renal cell carcinoma: a Mendelian randomization study.
    Chen M; Tsai CW; Chang WS; Xiong GY; Xu Y; Bau DT; Gu J
    Carcinogenesis; 2021 Jun; 42(6):826-830. PubMed ID: 33852723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.